We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+17.08%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$13.4B
AUM Growth
+$5.98B
(+81%)
Cap. Flow
+$4.58B
Cap. Flow
% of AUM
34.18%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$437M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
Amazon
AMZN
|
+$185M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$51.4M |
| 2 |
Lowe's Companies
LOW
|
+$45.3M |
| 3 |
CVS Health
CVS
|
+$37.3M |
| 4 |
Eli Lilly
LLY
|
+$32.7M |
| 5 |
Southern Company
SO
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Consumer Discretionary | 11.59% |
| 3 | Healthcare | 8.66% |
| 4 | Financials | 6.8% |
| 5 | Industrials | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Madrigal Pharmaceuticals
MDGL
$12.6B
| $346K | ﹤0.01% |
3,112
-1,641
| -35% | -$201K |
|
2102
Olin
OLN
$2.64B
| $346K | ﹤0.01% |
14,083
-118,782
| -89% | -$2.42M |
|
|
RYZ
2103
Ryerson Holding Corp
RYZ
$1.6B
| $346K | ﹤0.01% |
25,363
-28,448
| -53% | -$279K |
|
|
TBI
2104
Trueblue
TBI
$234M
| $346K | ﹤0.01% |
+18,539
| New | +$333K |
|
2105
CALL
Walt Disney
DIS
$165B
| $344K | ﹤0.01% |
1,900
-400
| -17% | -$57.4K |
|
|
AGS
2106
DELISTED
PlayAGS
AGS
| $343K | ﹤0.01% |
+47,682
| New | +$217K |
|
2107
Immersion
IMMR
$216M
| $343K | ﹤0.01% |
30,416
-14,572
| -32% | -$116K |
|
2108
JELD-WEN Holding
JELD
$94.8M
| $343K | ﹤0.01% |
+13,515
| New | +$324K |
|
2109
CALL
JPMorgan Chase
JPM
$939B
| $343K | ﹤0.01% |
2,700
-1,100
| -29% | -$123K |
|
|
SINA
2110
DELISTED
Sina Corp
SINA
| $343K | ﹤0.01% |
8,087
+1,573
| +24% | +$67.6K |
|
|
CPRX
2111
DELISTED
Catalyst Pharmaceutical
CPRX
| $342K | ﹤0.01% |
102,356
+38,099
| +59% | +$128K |
|
2112
Pebblebrook Hotel Trust
PEB
$2.16B
| $342K | ﹤0.01% |
18,207
+2,853
| +19% | +$46.2K |
|
|
AMK
2113
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $342K | ﹤0.01% |
+14,112
| New | +$334K |
|
2114
Acushnet Holdings
GOLF
$6.13B
| $341K | ﹤0.01% |
8,405
-4,044
| -32% | -$151K |
|
2115
Protagonist Therapeutics
PTGX
$8.75B
| $341K | ﹤0.01% |
+16,893
| New | +$364K |
|
2116
Transmedics
TMDX
$2.5B
| $341K | ﹤0.01% |
17,140
+4,440
| +35% | +$65.7K |
|
|
LGTY
2117
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $341K | ﹤0.01% |
19,873
+1,318
| +7% | +$21K |
|
|
ITCI
2118
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $341K | ﹤0.01% |
10,728
-33,746
| -76% | -$887K |
|
2119
CVB Financial
CVBF
$3.98B
| $339K | ﹤0.01% |
+17,372
| New | +$329K |
|
|
SI
2120
DELISTED
Silvergate Capital Corporation
SI
| $339K | ﹤0.01% |
+4,567
| New | +$151K |
|
|
HMSY
2121
DELISTED
HMS Holdings Corp.
HMSY
| $338K | ﹤0.01% |
9,188
-33,411
| -78% | -$1.01M |
|
2122
Haverty Furniture Companies
HVT
$401M
| $337K | ﹤0.01% |
12,170
-33,667
| -73% | -$889K |
|
|
NETI
2123
DELISTED
Eneti Inc.
NETI
| $337K | ﹤0.01% |
+19,877
| New | +$297K |
|
|
RPAI
2124
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $336K | ﹤0.01% |
39,299
-38,634
| -50% | -$282K |
|
2125
Customers Bancorp
CUBI
$2.59B
| $334K | ﹤0.01% |
18,378
+1,978
| +12% | +$31.4K |
|
Similar funds
Squarepoint's Q4 2020 Portfolio in Review
As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Squarepoint deployed $4.58B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.
- Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
- Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
- Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
- Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
- Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
- Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.
Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.